CD4 and neoplasm: In mice, using an early-stage and late-stage disease model of melanoma, we demonstrated that tumor size impacts on the tumor immune microenvironment (TIME), consistent with other data with differing disease burdens,12 13 and that a further feature of dysfunctional immunity in larger tumors is differences in CD4+TCR engagement with antigen.